Hutch News
Results per Page:
Community virus surveillance can double the data of vaccine trials
From Mr. Craig Magaret, Vaccine and Infectious Disease Division
Does HIV disease progression differ by ancestry?
From Drs. Shuying (Sue) Li and Peter Gilbert, Vaccine and Infectious Disease Division
Best allocation protocol for limited cholera vaccines
From the direction of Dr. Laura Matrajt, Vaccine and Infectious Disease Division
A unique population of mucosal Tregs respond to local viral infection
From the Lund and Prlic labs, Vaccine and Infectious Disease Division
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation
NIAID director’s determined spirit recognized with honorary Hutch Award
Are revisions to remdesivir dosing needed for treating SARS-CoV-2?
From the Schiffer lab, Clinical Research and Vaccine and Infectious Disease Divisions
New immunotherapy targets discovered for head and neck cancer
From the Prlic lab, Clinical Research and Vaccine and Infectious Disease Divisions
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Can estrogen improve vaginal health for postmenopausal women?
From the Fredricks lab, Vaccine and Infectious Disease and Clinical Research Divisions
Optimizing antigen design may improve HIV vaccine efforts
From the Pancera, McElrath and Stamatatos labs, Vaccine and Infectious Disease and Clinical Research Divisions
Researchers advance development of potential Epstein-Barr virus vaccines
Stakes raised as common virus linked to more diseases
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
Solid tumors use a type of T cell as a shield against immune attack
Discovery in head and neck cancers may open door for targeted immune-boosting drugs
Science Says: Comedian, researchers tackle tough topics
Trevor Noah and scientists discuss colorectal cancer screening, community involvement in research, science communication
Team of top researchers prepares for endemic COVID-19
$15M Howard Hughes Medical Institute grant shared by 8 scientists at Fred Hutch and UW
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology
Phase 1 trial aims to build on response seen in proof-of-concept trial
Tackling the unknowns of long-haul COVID-19
Fred Hutch and UW researchers are working together to better understand and treat the syndrome
Tip Sheet: New findings on immune response to COVID-19, new research from San Antonio Breast Cancer Symposium — and Fred Hutch expert predictions for 2022
Summaries of recent Fred Hutch research findings and other news